A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-05-11) →
What happened
ImmuneOncia Therapeutics updated the terms of a new share issuance to raise US$80.9M, about 37.7% of its market value.
For context, this raise equals about 37.7% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$80.9M |
| vs. market value | 37.7% |
| Filed | 2026-03-04, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260304001170 → open original filing |
Versions of this filing
- 2026-02-06Original
- 2026-03-04Amendment 1 (this page)
- 2026-04-02Amendment 2
- 2026-05-11Amendment 3
Source: DART. Information only, not investment advice.